Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 Next >
Wegovy helps reduce heart failure symptoms in obese people, study says
Tags Science Companies Health & Science
From CNBC.com News
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
Tags Medication Retail industry Business News
From CNBC.com News
Weight loss drugs are priced substantially higher in the U.S. than in other countries, analysis says
Tags Health care industry Business News Biotech and Pharmaceuticals
From CNBC.com News
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
Tags Novo Nordisk A/S US: News Business
From CNBC.com News
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
Tags Health & Science Companies Weight management
From CNBC.com News
Wegovy-maker Novo Nordisk sales soar 30% on strong demand for its weight-loss drug
Tags Earnings Novo Nordisk A/S Health & Science
From CNBC.com News
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
Tags Medicare health plans Weight loss surgery Breaking news
From CNBC.com News
Obesity drug Wegovy's landmark trial result could 'open up' health insurance access, analyst says
Tags LVMH Moet Hennessy Louis Vuitton SE Drug Retail Pharmaceuticals
From CNBC.com News
Stocks making the biggest moves midday: Beyond Meat, Chegg, PNC Financial, Dish & more
Tags International Flavors & Fragrances Inc DISH Network Corp Datadog Inc
From CNBC.com News
Stocks making the biggest moves premarket: UPS, Lucid, Beyond Meat, Novo Nordisk and more
Tags Palantir Technologies Inc Finance Beyond Meat Inc
From CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
Tags Health care industry Biotech and Pharmaceuticals Business News
From CNBC.com News
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
Tags AstraZeneca PLC Pharmaceuticals Breaking news
From CNBC.com News
Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait
Tags Health care industry Business Europe News
From CNBC.com News
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
Tags Health care industry Diabetes Mergers and acquisitions
From CNBC.com News
Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says
Tags Novo Nordisk A/S Biotechnology Sanofi SA
From CNBC.com News
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
Tags US: News Business Biotechnology
From CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
Tags Obesity Novo Nordisk A/S Business
From CNBC.com News
Stocks making the biggest moves midday: Shutterstock, Newell Brands, Zillow and more
Tags Stock markets Market Insider Newell Brands Inc
From CNBC.com News
European regulator to review weight-loss drugs following reports of suicidal thoughts
Tags Health Care Supplies Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Moderna strikes deal to develop mRNA drugs in China
Tags AstraZeneca PLC Foreign policy Pharmaceuticals
From CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
Tags Novo Nordisk A/S Surgical procedures Biotechnology
From CNBC.com News
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
Tags Eli Lilly and Co Weight management Health & Science
From CNBC.com News
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
Tags Pharmaceuticals Novo Nordisk A/S Business
From CNBC.com News
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
Tags Companies Health & Science Science
From CNBC.com News
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
Tags Business US: News Biotechnology
From CNBC.com News
Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
Tickers LAW LAWS
Tags Biotechnology Business US: News
From CNBC.com News
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
Tags Novo Nordisk A/S Obesity Medication
From CNBC.com News
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
Tags Politics Eli Lilly and Co Breaking News: Politics
From CNBC.com News
Novo Nordisk cuts some U.S. supply of Wegovy obesity drug as demand soars
Tags Business News Biotech and Pharmaceuticals Medicine
From CNBC.com News
Obesity drug industry could be worth $200 billion within the decade, says Barclays, as market valuations grow
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health Care Services
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.